Emerging therapies in gastrointestinal cancers

doi:10.3748/wjg.v12.i46.7440

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5530)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

367

HTML

4557

Figures (1-4)

228

Tables (1-2)

378

Sum=5530

Dec 14, 2006 (publication date) through Nov 15, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Dec 14, 2006; 12(46): 7440-7450
Published online Dec 14, 2006. doi: 10.3748/wjg.v12.i46.7440

Full Size Figure Download Figure

Figure 1 Schematic representation of the four ErbB family members and their respective ligands. The numbers depict percentage homology of each domain relative to EGFR/ErbB-1. There are no known ligands for ErbB-2 and the tyrosine kinase domain is non-functional in ErbB-3, as marked with a cross.

Citation: Nautiyal J, Rishi AK, Majumdar AP. Emerging therapies in gastrointestinal cancers. World J Gastroenterol 2006; 12(46): 7440-7450
URL: https://www.wjgnet.com/1007-9327/full/v12/i46/7440.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i46.7440